The results of a meta-analysis which pooled data from 134 RCTs suggest that the use of DPP-4 inhibitors is not significantly associated with an increased risk of acute pancreatitis (Nachnani et al., 2010). This evidence concerns the gene DPP4 and acute pancreatitis.